Palomar Medical Technologies To Host Second Quarter 2009 Financial Results Conference Call and Webcast on July 30, 2009
23 7월 2009 - 11:00PM
PR Newswire (US)
BURLINGTON, Mass., July 23 /PRNewswire-FirstCall/ -- Palomar
Medical Technologies, Inc. (NASDAQ:PMTI), a leading researcher and
developer of light-based systems for cosmetic treatments, will hold
its quarterly conference call of its 2009 second quarter financial
results on Thursday, July 30, 2009 at 11:30 AM Eastern Time. If you
would like to participate, please call (866) 783-2146 at 11:20 AM
Eastern Time on that day. The telephone replay will be available
one hour after the call at (888) 286-8010 passcode 72567268 and
continue through Thursday, August 13, 2009. A live webcast of
Palomar's conference call will be available in the Investor
Relations' section of the Company's web site
http://www.palomarmedical.com/. Institutional investors can access
the call via Thomson Financial's password-protected event
management site, StreetEvents (http://www.streetevents.com/). The
online archive will be available one hour after the call and
continue through Thursday, August 13, 2009. For more information on
Palomar and its products, visit Palomar's website at
http://www.palomarmedical.com/. To continue receiving the most
up-to-date information and latest news on Palomar as it happens,
sign up to receive automatic e-mail alerts by going to the Investor
Relations' section of the website. About Palomar Medical
Technologies Inc.: Palomar is a leading researcher and developer of
light-based systems for cosmetic treatments. Palomar pioneered the
optical hair removal field, when, in 1997, it introduced the first
high-powered laser hair removal system. Since then, many of the
major advances in light-based hair removal have been based on
Palomar technology. In December 2006, Palomar became the first
company to receive a 510(k) over-the-counter (OTC) clearance from
the United States Food and Drug Administration (FDA) for a new,
patented, home use, light-based hair removal device. In June 2009,
Palomar became the first company to receive a 510(k) OTC clearance
from the FDA for a new, patented home use, laser device for the
treatment of periorbital wrinkles. OTC clearance allows products to
be marketed and sold directly to consumers without a prescription.
There are now millions of light-based cosmetic procedures performed
around the world every year in physician offices, clinics, spas and
salons. Palomar is testing many new and exciting applications to
further advance hair removal, skin rejuvenation and other cosmetic
applications. Palomar is focused on developing proprietary
light-based technology for introduction to the mass markets.
Palomar has granted The Procter & Gamble Company a
non-exclusive license to certain patents, technology and FDA
documents related to the home-use, light-based hair removal field
for women. In addition, Palomar has an exclusive development and
license agreement with Johnson & Johnson Consumer Companies to
develop and potentially commercialize home-use, light-based devices
for reducing or reshaping body fat including cellulite, reducing
the appearance of skin aging, and reducing or preventing acne.
Contacts: Kayla Castle Investor Relations Manager Palomar Medical
Technologies, Inc. 781-993-2411 DATASOURCE: Palomar Medical
Technologies, Inc. CONTACT: Kayla Castle, Investor Relations
Manager of Palomar Medical Technologies, Inc., +1-781-993-2411, Web
Site: http://www.palomarmedical.com/
Copyright